General
EBF was founded in 2006 at the initiative of 12 pharmaceutical companies. Its goal was to create a platform for discussions around science, day-to-day procedures, business tools, technologies and regulatory issues in Bioanalysis. Until 2010, EBF membership was limited to pharmaceutical R&D companies with bioanalytical activities in Europe. From 2011 onwards, the EBF welcomed CROs having regulated BioA lab-activities in Europe. In 2010, the EBF registered as a non-profit organisation (vzw) (the Belgian Act of 27 June 1921 on non-profit associations, international non-profit associations and foundations. The EBF non-profit organisation was integrated into the Belgian Code on Companies and Associations (the BCCA) in 2023.
The EBF organises four meeting formats which are open to all: Focus Workshops (FWs, Spring and Autumn), the Open Symposium (OS), Roadshows and the Young Scientist Symposium (including the EBF University since 2022).
For more information on our meetings, go to https://meetings.e-b-f.eu/
Steering Committee
The day-to-day management is delegated from the Management Body of the Association to a Steering Committee.
EBF Mission
- Our mission is to share, discuss, optimize and seek alignment on a broad array of bioanalytical topics including science, procedures, business tools and technology, and regulatory issues.
- Internal discussions within EBF aim to recommend or influence opinions/procedures towards our members, business partners, regulatory bodies and any other stakeholders.
- Going forward, EBF is providing guidance and recommendations to the European and Global bioanalytical community
- Finally, provide development opportunities for EU based scientist by joining cross company collaborations and contributions to peer reviewed journals, international meetings and symposia